Bio for Elisabeth Wegner, M.D. Elisabeth Wegner, M.D.Associate Professor and Residency Program DirectorDepartment of Obstetrics, Gynecology and Reproductive Sciences Contact Information E-mail: Elisabeth.Wegner@uvm.eduPhone: 802-847-1400Office Location: Obstetrics, Gynecology and Reproductive Sciences, MFU - Smith 420, 111 Colchester Avenue, Burlington, VT 05401 Education1996 Residency - University of Vermont College of Medicine, Burlington, VT1992 M.D - University of Connecticut School of Medicine, Farmington, CT1986 B.A. - University of Vermont, Burlington, VT, BiologyResearch InterestsColposcopy, Human Papilloma Virus (HPV), Vulvovaginal disease, General OB/GYN, Gyn ultrasoundCurrent Research Projects: Currently principle investigator of site for a multicenter HPV phase III vaccine trial.Currently investigating disease status and HPV status of treatment specimens from women with cervical dysplasia.Awards and Honors2005, 2008, 2013 CREOG National Faculty Award for excellence in resident education2003, 2005, 2009 Outstanding Teacher Award, chief residents' award, OB/Gyn, University of Vermont2004 Colposcopy Recognition Award, American Society for Colposcopy and Cervical Pathology1995 Best Resident Teacher Award, University of Vermont Medical School Class of 1995PublicationsWegner EK, Bernstein IM. (2001 - present) Operative vaginal delivery. In UpToDate, Rose, BD(Ed), from http://www.uptodate.com/contents/operative-vaginal-deliveryHannaford K, Reeves S, Wegner E. Umbilical cord cysts in the first trimester: are they associated with pregnancy complications? J Ultrasound Med. 2013 May;32(5):801-6. doi: 10.7863/ultra.32.5.801. PubMed PMID: 23620322.Wegner EK and Bernstein IM. When’s the right time for operative vaginal delivery? Contemporary OB/GYN, 01 April 2005, vol./is. 50/4(40-45)Mount SL, Wegner EK, Eltabbakh GH, Olmstead JI, Drejet AE. Significant increase of benign endometrial cells on Papanicolaou smears in women using hormone replacement therapy. Obstet Gynecol. 2002 Sep;100(3):445-50. PubMed PMID: 12220762.Schaff EA, et al. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial. JAMA. 2000 Oct 18;284(15):1948-53. Erratum in: JAMA 2000 Nov 22-29;284(20):2597. PubMed PMID: 11035891.See PubMed listing here.